NantWorks, LLC applies new innovative approaches and new technologies to solving global problems. NantWorks™ is the parent company of various private and public entities focusing on three pillars: health & life sciences; energy & renewables; and connectivity & communications.
 
Founded by Dr. Patrick Soon-Shiong, scientist and inventor of the first human nanoparticle chemotherapeutic agent Abraxane, the core mission for NantWorks is convergence: to develop and deliver a diverse range of technologies that accelerate innovation, broaden the scope of scientific discovery, enhance ground-breaking research, and improve healthcare treatment for those in need.